Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease

Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease

Background: COVID-19 induces acute and long-term neurological symptoms. Links between COVID-19 neurological disturbance and Alzheimer’s disease (AD) have been hypothesized because neuroinflammation plays a significant role in both diseases. However, it is unknown if COVID-19 patients with neurologic...

Full description

Saved in:
Bibliographic Details
Main Authors: Fernanda G.Q. Barros-Aragão, Thaís L. Pinheiro, Talita P. Pinto, Bart Vanderborgh, Nathane B.S. Rezende, Guilherme B. de Freitas, Gabriel R. de Freitas, Fernando A. Bozza, Andrea S. Souza, Erika C. Rodrigues, Carlos O. Brandão, Paulo Mattos, Felipe K. Sudo, Fernanda F. Tovar-Moll, Fernanda G. De Felice
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Coronavirus
Neuroinflammation
Biomarkers
Dementia
Long-COVID
ATN
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354625000651
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items